Race Oncology Ltd targets multiple cancer indications as it advances Zantrene

Clinical stage RNA focused company targeting multiple cancer indications with estimated annual oncology revenues of >US$2.6 billion

Related Keywords

Australia ,United States ,Australian ,Daniel Tillett ,Chaim Sheba ,Aaron Sverdlov ,Doan Ngo ,Xu Dong Zhang ,Nikki Verrills ,Phillip Lynch ,Race Oncology Ltd ,University Of Newcastle ,Acute Myeloid Leukaemia ,Australian Phase ,Three Pillar ,Professor Nagler ,Chaim Sheba Israel ,Professor Xu Dong Zhang ,Associate Professor Lei Jin ,Associate Professors Aaron Sverdlov ,Associate Professor Nikki Verrills ,